关注
Anastasiia Kotliarova
Anastasiia Kotliarova
在 helsinki.fi 的电子邮件经过验证
标题
引用次数
引用次数
年份
Electrospun fibers and sorbents as a possible basis for effective composite wound dressings
AS Álvarez-Suárez, SG Dastager, N Bogdanchikova, D Grande, ...
Micromachines 11 (4), 441, 2020
372020
Glial cell line-derived neurotrophic factor family ligands, players at the interface of neuroinflammation and neuroprotection: focus onto the glia
A Kotliarova, YA Sidorova
Frontiers in cellular neuroscience 15, 679034, 2021
322021
Silver containing sorbents: Physicochemical and biological properties
LN Rachkovskaya, TV Popova, AY Letyagin, TG Tolstikova, MA Korolyov, ...
Resource-Efficient Technologies 2 (2), 43-49, 2016
142016
A Newly Identified Monoterpenoid-Based Small Molecule Able to Support the Survival of Primary Cultured Dopamine Neurons and Alleviate MPTP-Induced Toxicity In Vivo
A Kotliarova, AV Podturkina, AV Pavlova, DS Gorina, AV Lastovka, ...
Molecules 27 (23), 8286, 2022
92022
The possibility of creating multifunctional silver-containing drugs with detoxifying effect
TV Popova, NO Karabinceva, LN Rachkovskaya, TG Tolstikova, ...
Pharmacy & Pharmacology 5 (3), 242-253, 2017
92017
The effect of 3, 7-diazabicyclo3. 3.1 nonanes containing monoterpenoid moieties on the physical activity of mice
AA Kotlyarova, KY Ponomarev, EA Morozova, DV Korchagina, EV Suslov, ...
J. Res. Pharm 24 (2), 196, 2020
82020
Влияние новой мазевой композиции ag/тага и хитозан-геля на лечение экспериментальных ран различной этиологии
ТВ Попова, ТГ Толстикова, АЮ Летягин, НА Жукова, НП Бгатова, ...
Бюллетень сибирской медицины 15 (1), 48-55, 2016
82016
Evaluation of the anti-viral activity of human recombinant interferon lambda-1 against SARS-CoV-2
PG Madonov, VA Svyatchenko, SS Legostaev, NA Kikhtenko, ...
Bulletin of Experimental Biology and Medicine 172, 53-56, 2021
62021
In vitro and in vivo effect of the composition of fucoxanthin with porous aluminum-silicon career on cells
A Lykov, L Rachkovskaya, M Surovtseva, I Kim, R Gevorgiz, S Zheleznova, ...
Biointerface Res. Appl. Chem 11 (2), 9467-9476, 2021
62021
Biological Activity In Vitro, Absorption, BBB Penetration, and Tolerability of Nanoformulation of BT44:RET Agonist with Disease-Modifying Potential for the …
MS Haider, AK Mahato, A Kotliarova, S Forster, B Böttcher, P Stahlhut, ...
Biomacromolecules 24 (10), 4348-4365, 2022
52022
The possibilities of safe lithium therapy in Treatment of neurological psychoemotional disorders
AV Shurlygina, LN Rachkovskaya, MV Robinson, AA Kotlyarova, ...
In the book: The Boundaries of Clinical Medicine Research-CNS and …, 2021
42021
Toxicity of fucoxanthin on Balb/c mice splenocytes and thymocytes
A Lykov, E Rachkovsky, R Gevorgiz, S Zheleznova, A Kotlyarova
2020 Cognitive Sciences, Genomics and Bioinformatics (CSGB), 277-280, 2020
42020
The effect of a new drug based on a complex lithium citrate polymethylsiloxane and aluminum oxide on the adaptation of animals to physical exertion social adaptation and …
VI Konenkov, LN Rachkovskaya, AY Letyagin, NI Suslov, AV Shurlygina, ...
Bulletin of experimental biology and medicine 82 (1), 3-7, 2019
42019
Correction of lithium of neurodegenerative damage in alcoholism: the cellular and molecular mechanisms
AA Kotlyarova, AY Letyagin, TG Tolstikova, LN Rachkovskaya, ...
Vestn. NSU Ser. Biol. Clin. Med. 13, 56-66, 2015
42015
MECHANISMS OF ACTION OF LITHIUM COMPOUNDS
MV Robinson, AA Kotlyarova, AV Shurlygina, LN Rachkovskaya, ...
Сибирский научный медицинский журнал 39 (5), 19-28, 2019
32019
Modified sorbents for pharmacology
YI Borodin, LN Rachkovskaya, TV Popova, AA Kotlyarova, SV Michurina, ...
2018 11th International Multiconference Bioinformatics of Genome Regulation …, 2018
32018
The influence of the complex of lithium citrate, polymethylsyloxane and aluminum oxide on conditional reflector behavior of intact mice and mice with caffeine and alcohol …
VI Konenkov, LN Rachkovskaya, AY Letjagin, NI Suslov, AV Shurlugina, ...
Rossiyskiy fiziologicheskiy zhurnal im. IM Sechenova 103 (10), 1125-1134, 2017
32017
Antiviral activity against SARS-CoV-2 of a pharmaceutical substance based on immobilized recombinant human interferon lambda-1
PG Madonov, VA Svyatchenko, SS Legostaev, NA Kikhtenko, ...
Eksp. Klin. Farmakol 84 (7), 15-20, 2021
22021
ИЗУЧЕНИЕ ВОЗМОЖНЫХ МУТАГЕННЫХ СВОЙСТВ НОВОГО ЛЕКАРСТВЕННОГО СРЕДСТВА НА ОСНОВЕ КОМПЛЕКСА ЛИТИЯ, ОКСИДА АЛЮМИНИЯ И ПОЛИМЕТИЛСИЛОКСАНА
ВИ Коненков, МА Королев, АА Чурин, ОЛ Воронова, ОВ Неупокоева, ...
Сибирский научный медицинский журнал 39 (5), 62-67, 2019
22019
Porous sorbent with normothymic properties based on aluminium oxide
LN Rachkovskaya, AA Kotlyarova, IS Darneva, NP Bgatova, ...
RU patent, 2017
22017
系统目前无法执行此操作,请稍后再试。
文章 1–20